Leman Biotech Co., Ltd. announced that it has received CNY 50 million in a round of funding from new investor FUHO Capital Management Co., Ltd. on June 17, 2024. The transaction included participation from new investor Henan Yunfan Electronic Technology Co., Ltd, returning investors XtalPi Inc., Tian Tu Capital Co., Ltd. and private financial investors and individual investors.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3 CNY | 0.00% |
|
-11.76% | -54.34% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-54.34% | 266M | |
-2.61% | 117B | |
+4.29% | 97.34B | |
+28.55% | 68.17B | |
+9.07% | 66.89B | |
+15.04% | 45.22B | |
+13.77% | 43.11B | |
+23.83% | 37.3B | |
+6.59% | 25.85B | |
-4.83% | 22.34B |
- Stock Market
- Equities
- 1973 Stock
- News Shenzhen Tiantu Capital Co., Ltd.
- Leman Biotech Co., Ltd. announced that it has received CNY 50 million in funding from FUHO Capital Management Co., Ltd., XtalPi Inc., Henan Yunfan Electronic Technology Co., Ltd., Tian Tu Capital Co., Ltd. and other investors